iSTAR Medical Raises EUR 4 million in Series A Financing

Proceeds to Support Advancement of STARfloTM Glaucoma Implant

Isnes, Belgium (November 21, 2013) – iSTAR Medical SA, a privately held ophthalmic device company and first spinout of Healionics Corporation, today announced it has raised EUR 4.0 million from institutional investors in a Series A financing. The financing was coled by Capricorn Health-Tech Fund NV (CHF) and Société Régionale d’Investissement de Wallonie (SRIW), and included participation from Financière Spin-off Luxembourgeoise (INVESTSUD Group) and Namur Invest – Preface.

Read more

iSTAR Medical adds Dr. Lim to SAB

For Immediate Release

Isnes, Belgium (October 9, 2012) – iSTAR Medical SA (iSTAR), a medical device company specializing in ophthalmic implants, announced today the addition of Sheng Lim, MD, to its Scientific Advisory Board (SAB).

Read more

iSTAR Medical wins €3.6m grant for STARflo™ PLUS

Isnes, Belgium (September 14, 2012)iSTAR Medical SA announced today that its STARflo PLUS™ project was awarded a €3,6 million collaborative research grant from Belgium’s Région Wallonne government in coordination with the region’s health competitiveness cluster BioWin.

Read more